Immunohistology of Head and Neck Neoplasms

Diagnostic Immunohistochemistry, Second Edition

Volumn , Issue , 2006, Pages 227-260

  Hunt, Jennifer L ^a   Barnes, Leon ^b,c,d  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902392443     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06652-8.50014-4     Document Type: Chapter

References (205)

1. JP Simons, JL Hunt and JT Johnson (2003) Pathology quiz case. Granular cell tumor of the tongue, with extensive overlying pseudoepitheliomatous hyperplasia. Arch Otolaryngol Head Neck Surg 129 127-128.
2. L Lassaletta, S Alonso, J Granell, et al. (1998) Synchronous glottic granular cell tumor and subglottic spindle cell carcinoma. Arch Otolaryngol Head Neck Surg 124 1031-1034.
3. GA Barkan and AF Paulino (2003) Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors? Ann Diagn Pathol 7 73-77.
4. BM Wenig (2002) Squamous cell carcinoma of the upper aerodigestive tract: precursor and problematic variants. Mod Pathol 15 229-254.
5. MG van Oijen, V. Leppers Vd, FG Straat, MG Tilanus, et al. (2000) The origins of multiple squamous cell carcinomas in the aerodigestive tract. Cancer 88 884-893.
6. EM Sturgis and Q Wei (2002) Genetic susceptibility – molecular epidemiology of head and neck cancer. Curr Opin Oncol 14 310-317.
7. DL Crowe, JG Hacia, CL Hsieh, et al. (2002) Molecular pathology of head and neck cancer. Histol Histopathol 17 909-914.
8. MG van Oijen and PJ Slootweg (2000) Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarker Prevent 9 249-256.
9. BJ Jacob, K Straif, G Thomas, et al. (2004) Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol 40 697-704.
10. DC Sharma (2003) Betel quid and areca nut are carcinogenic without tobacco. Lancet Oncol 4 587.
11. R Herrero, X Castellsague, M Pawlita, et al. (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95 1772-1783.
12. HC Hafkamp, EJ Speel, A Haesevoets, et al. (2003) A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8. Int J Cancer 107 394-400.
13. PK Ha, SI Pai, WH Westra, et al. (2002) Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8 1203-1209.
14. ML Gillison and KV Shah (2001) Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13 183-188.
15. AT Hesselink, AJ van den Brule, AA Brink, et al. (2004) Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples. Cancer 102 11-18.
16. F McGregor, A Muntoni, J Fleming, et al. (2002) Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine. Cancer Res 62 4757-4766.
17. J Sudbo, SM Lippman, JJ Lee, et al. (2004) The influence of resection and aneuploidy on mortality in oral leukoplakia. [see comment]. N Engl J Med 350 1405-1413.
18. WM Lydiatt, PE Anderson, T Bazzana, et al. (1998) Molecular support for field cancerization in the head and neck. Cancer 82 1376-1380.
19. JR Saunders Jr (1997) The genetic basis of head and neck carcinoma. Am J Surg 174 459-461.
20. W Fiedler, C Hoppe, B Schimmel, et al. (2002) Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Int J Molec Med 9 417-423.
21. JG Vartanian, E Pontes, IM Agra, et al. (2003) Distribution of metastatic lymph nodes in oropharyngeal carcinoma and its implications for the elective treatment of the neck. Arch Otolarygol Head Neck Surg 129 729-732.
22. PJ Slootweg, GJ Hordijk, Y Schade, et al. (2002) Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. Oral Oncol 38 500-503.
23. HT Hoffman (2001) Surgical treatment of cervical node metastases from squamous cell carcinoma of the upper aerodigestive tract: evaluation of the evidence for modifications of neck dissection. Head Neck 23 907-915.
24. AF Paulino, B Singh, JP Shah, et al. (2000) Basaloid squamous cell carcinoma of the head and neck. Laryngoscope 110 1479-1482.
25. B Erdamar, Y Suoglu, C Cuhadaroglu, et al. (2000) Basaloid squamous cell carcinoma of the supraglottic larynx. Eur Arch Oto-Rhino-Laryngol 257 154-157.
26. SM Winzenburg, GA Niehans, E George, et al. (1998) Basaloid squamous carcinoma: a clinical comparison of two histologic types with poorly differentiated squamous cell carcinoma. Otolaryngol Head Neck Surg 119 471-475.
27. L Barnes, A Ferlito, G Altavilla, et al. (1996) Basaloid squamous cell carcinoma of the head and neck: clinicopathological features and differential diagnosis. Ann Otol Rhinol Laryngol 105 75-82.
28. A Ferlito, G Altavilla, A Rinaldo, et al. (1997) Basaloid squamous cell carcinoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol 106 1024-1035.
29. M Poetsch, G Lorenz, A Bankau, et al. (2003) Basaloid in contrast to nonbasaloid head and neck squamous cell carcinomas display aberrations especially in cell cycle control genes. Head Neck 25 904-910.
30. ML Gillison, WM Koch, RB Capone, et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 709-720.
31. S Muller and EL Barnes (1995) Basaloid squamous cell carcinoma of the head and neck with a spindle cell component. An unusual histologic variant. Arc Pathol Lab Med 119 181-182.
32. F Ide, T Shimoyama, N Horie, et al. (2002) Basaloid squamous cell carcinoma of the oral mucosa: a new case and review of 45 cases in the literature. Oral Oncol 38 120-124.
33. WF Raslan, L Barnes, JR Krause, et al. (1994) Basaloid squamous cell carcinoma of the head and neck: a clinicopathologic and flow cytometric study of 10 new cases with review of the English literature. Am J Otolaryngol 15 204-211.
34. J Klijanienko, A el-Naggar, F De Brand, et al. (1993) Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 119 887-890.
35. RD Coletta, P Cotrim, OP Almeida, et al. (2002) Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study. Oral Oncol 38 723-729.
36. ER Banks, HF Frierson Jr, SE Mills, et al. (1992) Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 16 939-946.
37. WG Morice and JA Ferreiro (1998) Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Human Pathol 29 609-612.
38. H Tsubochi, T Suzuki, S Suzuki, et al. (2000) Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract. Anticancer Res 20 1205-1211.
39. VA Holst, CE Marshall, CA Moskaluk, et al. (1999) KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 12 956-960.
40. M Mino, BZ Pilch and WC Faquin (2004) Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol 16 1224-1231.
41. T Kiyoshima, K Shima, I Kohayashi, et al. (2001) Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol 37 315-322.
42. T Owonikoko, C Loberg, HE Gabbert, et al. (2001) Comparative analysis of basaloid and typical squamous cell carcinoma of the oesophagus: a molecular biological and immunohistochemical study. J Pathol 193 155-161.
43. BB Kroch, DK Trask and HT Hoffman (2001) National survey of head and neck verrucous carcinoma: Patterns of presentation, care and outcome. Cancer 92 110-120.
44. EL Barnes and JL Hunt (2003) Squamous cell carcinoma of the oral cavity and oropharynx: A review of current data. Selected Readings in Oral and Maxillofacial Pathology 11 1-60.
45. JE Medina, W Dichtel and MA Luna (1984) Verrucous-squamous carcinomas of the oral cavity. A clinicopathologic study of 104 cases. Arch Otolaryngol 110 437-440.
46. A Ishiyama, LR Eversole, DA Ross, et al. (1994) Papillary squamous neoplasms of the head and neck. Laryngoscope 104 1446-1452.
47. PA Suarez, et al. (2000) Papillary squamous cell carcinomas of the upper aerodigestive tract: a clinicopathologic and molecular study. Head Neck 22 360-368.
48. LD Thompson, BM Wenig, DK Heffner, et al. (1999) Exophytic and papillary squamous cell carcinomas of the larynx: A clinicopathologic series of 104 cases. Otolaryngol Head Neck Surg 120 718-724.
49. LD Thompson, JA Wieneke, M Miettinen, et al. (2002) Spindle cell (sarcomatoid) carcinomas of the larynx: a clinicopathologic study of 187 cases. Am J Surg Pathol 26 153-170.
50. KD Olsen, JE Lewis and VJ Suman (1997) Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg 116 47-52.
51. JE Lewis, KD Olsen and TJ Sebo (1997) Spindle cell carcinoma of the larynx: review of 26 cases including DNA content and immunohistochemistry. Hum Pathol 28 664-673.
52. LD Thompson (1997) Diagnostically challenging lesions in head and neck pathology. Eur Arch Oto-Rhino-Laryngol 254 357-366.
53. SE Mills and RE Fechner (1989) ‘Undifferentiated’ neoplasms of the sinonasal region: differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Sem Diagn Pathol 6 316-328.
54. K Devaney, BM Wenig and SL Abbondanzo (1996) Olfactory neuroblastoma and other round cell lesions of the sinonasal region. Mod Pathol 9 658-663.
55. JM Meis-Kindblom, G Stenman and LG Kindblom (1996) Differential diagnosis of small round cell tumors. Sem Diagn Pathol 13 213-241.
56. K Devoe and N Weidner (2000) Immunohistochemistry of small round-cell tumors. Sem Diagn Pathol 17 216-224.
57. G Broich, A Pagliari and F Ottaviani (1997) Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 17 2683-2706.
58. P Dulguerov, AS Allal and TC Calcaterra (2001) Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2 683-690.
59. A Franchi, M Moroni, D Massi, et al. (1597) Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol 26 1597-1604.
60. LA Cerilli, VA Holst, MS Brandwein, et al. (2001) Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol 25 156-163.
61. JR Lopategui, MJ Gaffey, HF Frierson Jr, et al. (1994) Detection of Epstein-Barr viral RNA in sinonasal undifferentiated carcinoma from Western and Asian patients. Am J Surg Pathol 18 391-398.
62. RE Nakhleh, MR Wick, A Rocamora, et al. (1990) Morphologic diversity in malignant melanomas [see comment]. Am J Clin Pathol 93 731-740.
63. LD Thompson, M Miettinen and BM Wenig (2003) Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol 27 737-749.
64. ML Prasad, AA Jungbluth, K Iversen, et al. (2001) Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol 25 782-787.
65. DW Franquemont and SE Mills (1991) Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol 96 689-697.
66. EG Silva, JJ Butler and B Mackay (1980) Neuroblastomas and neuroendocrine carcinoma of the paranasal sinuses. A morphological and endocrinological study. Cancer 45 330-339.
67. MM Fitzek, AF Thoraton, M Uarvares, et al. (2002) Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy. Cancer 94 2623-2634.
68. B Perez-Ordonez, SM Caruana, AG Huvos, et al. (1998) Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses. Hum Pathol 29 826-832.
69. W Cheuk, MY Kwan, S Suster, et al. (2001) Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 125 228-231.
70. H Mineta, K Miura, S Takebayashi, et al. (2001) Immunohistochemical analysis of small cell carcinoma of the head and neck: a report of four patients and a review of sixteen patients in the literature with ectopic hormone production. Ann Otol Rhinol Laryngol 110 76-82.
71. SL Abbondanzo and BM Wenig (1995) Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 75 1281-1291.
72. RW Vidal, K Devaney, A Ferlito, et al. (1999) Sinonasal malignant lymphomas: a distinct clinicopathological category. Ann Otol Rhinol Laryngol 108 411-419.
73. DA Arber, LM Weiss, PF Albujar, et al. (1993) Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection [see comment]. Am J Surg Pathol 17 392-399.
74. MD Logsdon, CS Ha, VS Kavadi, et al. (1997) Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 80 477-488.
75. I Cuadra-Garcia, GM Proulx, CL Wu, et al. (1999) Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 23 1356-1369.
76. K Gaal, NC Sun, AM Hernandez, et al. (2000) Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 24 1511-1517.
77. C Alexiou, RJ Kau, H Dietzfelbirger, et al. (1999) Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts [see comment]. Cancer 85 2305-2314.
78. SB Kapadia, U Desai and VS Cheng (1982) Extramedullary plasmacytoma of the head and neck. A clinicopathologic study of 20 cases. Medicine 61 317-329.
79. NS Aquilera, SB Kapadia, MA Nalesnik, et al. (1995) Extramedullary plasmacytoma of the head and neck: use of paraffin sections to assess clonality with in situ hybridization, growth fraction, and the presence of Epstein-Barr virus. Mod Pathol 8 503-508.
80. RV Lloyd, WF Chandler, K Kovacs, et al. (1986) Ectopic pituitary adenomas with normal anterior pituitary glands. Am J Surg Pathol 10 546-552.
81. AG van der Mey, AP van Seters, JH van Krieken, et al. (1989) Large pituitary adenomas with extension into the nasopharynx. Report of three cases with a review of the literature. Ann Otol Rhinol Laryngol 98 618-624.
82. IS Luk, JK Chan, SM Chow, et al. (1996) Pituitary adenoma presenting as sinonasal tumor: pitfalls in diagnosis. Hum Pathol 27 605-609.
83. BJ O'Hara, A Paetau and M Miettinen (1998) Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 29 119-126.
84. SL Asa, LA Puy, AM Lew, et al. (1993) Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metabol 77 1275-1280.
85. HM Mauer, et al. (1988) The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 61 209-220.
86. TA Callender, RS Weber, N Janjan, et al. (1995) Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 112 252-257.
87. DM Parham, B Webber, H Holt, et al. (1991) Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma study project. Cancer 67 3072-3080.
88. MH Cessna, H Zhou, SL Perkins, et al. (2001) Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics. Am J Surg Pathol 25 1150-1157.
89. JE Jones and T McGill (1995) Peripheral primitive neuroectodermal tumors of the head and neck. Arch Otolaryngol Head Neck Surg 121 1392-1395.
90. NG Nikitakis, AR Salama, BW O'Malley Jr, et al. (2003) Malignant peripheral primitive neuroectodermal tumor-peripheral neuroepithelioma of the head and neck: a clinicopathologic study of five cases and review of the literature. Head Neck 25 488-498.
91. M Gu, CR Antonescu, G Guiter, et al. (2000) Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies [see comment]. Am J Surg Pathol 24 410-416.
92. E de Alava and WL Gerald (2000) Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 18 204-213.
93. AL Folpe, CE Hill, DM Parham, et al. (2000) Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 24 1657-1662.
94. L Barnes (1986) Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 10 192-202.
95. CD McKinney, SE Mills and DW Franquemont (1995) Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol 8 421-426.
96. JF Krane, JT O'Connel, BZ Pilch, et al. (2000) Sinonasal adenocarcinoma: Evidence for histogenetic divergence of the enteric and nonenteric phenotypes (Abstract). Mod Pathol 17 139A.
97. HR Choi, EM Sturgis, A Rashid, et al. (2003) Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes. Hum Patholo 34 1101-1107.
98. AA Bashir, RA Robinson, JA Benda, et al. (2003) Sinonasal adenocarcinoma: immunohistochemical marking and expression of oncoproteins. Head Neck 25 763-771.
99. A Franchi, D Massi, G Baroni, et al. (2003) CDX-2 homeobox gene expression [comment]. Am J Surg Pathol 27 1390-1391.
100. R Amre, V Ghali, G Elmberger, et al. (2004) Sinonasal ‘intestinal-type’ adenocarcinomas (SNITAC): An immunohistochemical (IHC) study of 22 cases (Abstract). Mod Pathol 17 221A.
101. PG Chu, KL Chang, AY Wu, et al. (1999) Nasal glomus tumors: report of two cases with emphasis on immunohistochemical features and differential diagnosis. Hum Pathol 30 1259-1261.
102. K Watanabe, A Saito, M Suzuki, et al. (2001) True hemangiopericytoma of the nasal cavity. Arch Pathol Lab Med 125 686-690.
103. LL Tse and JK Chan (2002) Sinonasal haemangiopericytoma-like tumour: a sinonasal glomus tumour or a haemangiopericytoma? Histopathology 40 510-517.
104. L Barnes, JW Eveson, PA Reichert and D Sindransky (2005) Pathology and genetics of head and neck tumours France: World Health Organization Lyons, IARC Press
105. P Dubey, CS Ha, KK Ang, et al. (1998) Nonnasopharyngeal lymphoepithelioma of the head and neck. Cancer 82 1556-1562.
106. YM Jeng, MT Sung, CL Fang, et al. (2002) Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol 26 371-376.
107. SY Leung, et al. (1995) Epstein-Barr virus is present in a wide histological spectrum of sinonasal carcinomas. Am J Surg Pathol 19 994-1001.
108. LF Sheu, A Chen, HH Tseng, et al. (1995) Assessment of p53 expression in nasopharyngeal carcinoma. Hum Pathol 26 380-386.
109. G Bar-Sela, A Kuten, S Ben-Eliezer, et al. (2003) Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach. Mod Pathol 16 1035-1040.
110. A Beham, J Kainz, H Stammberger, et al. (1997) Immunohistochemical and electron microscopical characterization of stromal cells in nasopharyngeal angiofibromas. Eur Arch Oto Rhino Laryngol 254 196-199.
111. A Beham, S Regauer, C Beham-Schmid, et al. (1998) Expression of CD34-antigen in nasopharyngeal angiofibromas. Int J Pediatr Otorhinolaryngol 44 245-250.
112. SC Abraham, EA Montgomery, FM Giardiello, et al. (2001) Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. Am J Pathol 158 1073-1078.
113. HC Hwang, SE Mills, K Patterson, et al. (1998) Expression of androgen receptors in nasopharyngeal angiofibroma: an immunohistochemical study of 24 cases. Mod Pathol 11 1122-1126.
114. AG Montag, MS Richardson and M Tretiakova (2004) Nasopharyngeal angiofibromas: Consistent expression of estrogen receptor beta (abstract). Mod Pathol 17 228A.
115. AC Filie, JM Lage and N Azumi (1996) Immunoreactivity of S100 protein, alpha-1-antitrypsin, and CD68 in adult and congenital granular cell tumors. Mod Pathol 9 888-892.
116. JC Fanburg-Smith, JM Meis-Kindblom, R Fante, et al. (1998) Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. [erratum appears in Am J Surg Pathol 1999;23(1):136]. Am J Surg Pathol 22 779-794.
117. SW Fine and M Li (2003) Expression of calretinin and the alpha-subunit of inhibin in granular cell tumors. Am J Clin Pathol 119 259-264.
118. BH Le, PJ Boyer, JE Lewis, et al. (2004) Granular cell tumor: immunohistochemical assessment of inhibin-alpha, protein gene product 9.5, S100 protein, CD68, and Ki-67 proliferative index with clinical correlation. Arch Pathol Lab Med 128 771-775.
119. BM Steinberg and TP DiLorenzo (1996) A possible role for human papillomaviruses in head and neck cancer. Cancer Metastasis Rev 15 91-112.
120. SE Mills (2002) Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol 15 264-278.
121. EL Barnes (1991) Paraganglioma of the larynx: A critical review of the literature. Ann Otol Rhinol Laryngol 53 220-234.
122. A el Naggar and JG Batsakis (1991) Carcinoid tumors of the larynx. A critical review of the literature. Ann Otol Rhinol Laryngol 53 185-187.
123. JM Woodruff and RT Senie (1991) Atypical carcinoid tumor of the larynx. Ann Otol Rhinol Laryngol 53 194-209.
124. DR Gnepp (1991) Small cell neuroendocrine carcinoma of the larynx: A critical review of the literature. Ann Otol Rhinol Laryngol 53 210-219.
125. CM Milroy and A Ferlito (1995) Immunohistochemical markers in the diagnosis of neuroendocrine neoplasms of the head and neck. Ann Otol Rhinol Laryngol 104 413-418.
126. JM Woodruff, AG Huvos, RA Erlandson, et al. (1985) Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma. Am J Surg Pathol 9 771-790.
127. AM Oliveira, HD Tazelaar, JL Myers, et al. (2001) Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites. Am J Surg Pathol 25 815-819.
128. V Vargas, D Sudilovsky, MJ Kaplan, et al. (1997) Mixed tumor, polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma of the salivary gland: pathogenic implications and differential diagnosis by Ki-67 (Mib 1), Bcl 2 and S-100 immunohistochemistry. Appl Immunohistochemist 5 8-16.
129. DR Gnepp and S el-Mofty (1997) Polymorphous low-grade adenocarcinoma: glial fibrillary acidic protein staining in the differential diagnosis with cellular mixed tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontic 83 691-695.
130. JT Castle, LD Thompson, RA Frommelt, et al. (1999) Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. Cancer 86 207-2019.
131. MR Darling, JW Schneider and VM Phillips (2002) Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol 38 641-645.
132. Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck:an ancillary marker for adenoid cystic carcinoma. Mod Pathol 1224;16:1224–1231.
133. PD Freedman and H Lumerman (1983) Lobular carcinoma of intraoral minor salivary gland origin. Report of twelve cases. Oral Surg Oral Med Oral Pathol 56 157-166.
134. JG Batsakis, GR Pinkston, MA Luna, et al. (1983) Adenocarcinomas of the oral cavity: a clinicopathologic study of terminal duct carcinomas. J Laryngol Otol 97 825-835.
135. DR Gnepp, JC Chen and C Warren (1988) Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study. Am J Surg Pathol 12 461-468.
136. T Nagao, et al. (2003) Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol 16 1265-1272.
137. AR Prasad, AT Savera, AM Gown, et al. (1999) The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med 123 801-806.
138. AT Savera and RJ Zarbo (2004) Defining the role of myoepithelium in salivary gland neoplasia. Adv Anatomic Pathol 11 69-85.
139. L Barnes, BN Appel, H Perez, et al. (1985) Myoepithelioma of the head and neck: case report and review. J Surg Oncol 28 21-28.
140. T Nagao, et al. (1998) Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases. Cancer 83 1292-1299.
141. AT Savera, A Sloman, AG Huvos, et al. (2000) Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol 24 761-774.
142. K Donath, G Seifert and R Schmitz (1972) [Diagnosis and ultrastructure of the tubular carcinoma of salivary gland ducts. Epithelial-myoepithelial carcinoma of the intercalated ducts]. Virchows Archiv A: Pathol Pathologische Anatomie 356 16-31.
143. KJ Cho, AK el-Naggar, NG Ordonez, et al. (1995) Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene. Am J Clin Pathol 103 432-437.
144. I Fronseca and J Soares (1993) Proliferating cell nuclear antigen immunohistochemistry in epithelial-myoepithelial carcinoma of the salivary glands. Arch Pathol Lab Med 117 993. 935
145. JC Rosa, A Felix, I Fonseca, et al. (1997) Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation. J Clin Pathol 50 661-663.
146. G Seifert (1996) Classification and differential diagnosis of clear and basal cell tumors of the salivary glands. Sem Diagn Pathol 13 95-103.
147. GL Ellis (1998) Clear cell neoplasms in salivary glands: clearly a diagnostic challenge. Ann Diagn Pathol 2 61-78.
148. GL Ellis and PL Auclair (1991) Malignant epithelial tumors. GL Ellis, PL Auclair, DR Gnepp (Eds) Surgical pathology of the salivary glands Philadelphia: WB Saunders 379-389.
149. B Wang, M Brandwein, R Gordon, et al. (2002) Primary salivary clear cell tumors – a diagnostic approach: a clinicopathologic and immunohistochemical study of 20 patients with clear cell carcinoma, clear cell myoepithelial carcinoma, and epithelial-myoepithelial carcinoma. Arch Pathol Lab Med 126 676-685.
150. M Michal, A Skalova, RH Simpson, et al. (1996) Clear cell malignant myoepithelioma of the salivary glands. Histopathology 28 309-315.
151. RB Rezende, CB Drachenburg, D Kumar, et al. (1999) Differential diagnosis between monomorphic clear cell adenocarcinoma of salivary glands and renal (clear) cell carcinoma. Am J Surg Pathol 23 1532-1538.
152. L Barnes, U Rao, J Knausse, et al. (1994) Salivary duct carcinoma. Part I. A clinicopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral Surg Oral Med Oral Pathol 78 64-73.
153. JE Lewis, BC McKinney, LH Weiland, et al. (1996) Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 77 223-230.
154. SB Kapadia and L Barnes (1998) Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol 11 1033-1038.
155. CY Fan, J Wang and EL Barnes (2000) Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol 24 579-586.
156. A Felix, el-Naggar, MF Press, et al. (1996) Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma. Hum Pathol 27 561-566.
157. A Skalova, I Starck, T Vanecek, et al. (2003) Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry [see comment]. Histopathology 42 348-356.
158. Y Tashiro, K Sueishi and K Nakao (1995) Nasal glioma: an immunohistochemical and ultrastructural study. Pathol Int 45 393-398.
159. HW Francis, GT Nager, MJ Holliday, et al. (1995) Association of heterotropic neuroglial tissue with an arachnoid cyst in the internal auditory canal. Skull Base Surg 5 37-49.
160. ME Glasscock 3rd, JR Dickins, CG Jackson, et al. (1979) Surgical management of brain tissue herniation into the middle ear and mastoid. Laryngoscope 89 1743-1754.
161. SE Mills and RE Fechner (1984) Middle ear adenoma. A cytologically uniform neoplasm displaying a variety of architectural patterns. Am J Surg Pathol 8 677-685.
162. KR Torske and LD Thompson (2002) Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature. Mod Pathol 15 543-555.
163. MJ Gaffey, SE Mills, RE Fechner, et al. (1988) Aggressive papillary middle-ear tumor. A clinicopathologic entity distinct from middle-ear adenoma [see comment]. Am J Surg Pathol 12 790-797.
164. DK Heffner (1989) Low-grade adenocarcinoma of probable endolymphatic sac origin A clinicopathologic study of 20 cases. Cancer 64 2292-2302.
165. MJ Gaffey, SE Mills and JC Boyd (1994) Aggressive papillary tumor of middle ear/temporal bone and adnexal papillary cyst-adenoma. Manifestations of von Hippel-Lindau disease. Am J Surg Pathol 18 1254-1260.
166. CA Megerian, BZ Pilch, AK Bhan, et al. (1997) Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus. Laryngoscope 107 216-221.
167. H Horiguchi, T Sano, H Toi, et al. (2001) Endolymphatic sac tumor associated with a von Hippel-Lindau disease patient: an immunohistochemical study. Mod Pathol 14 727-732.
168. KA Gyure and AL Morrison (2000) Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. Mod Pathol 13 638-643.
169. LD Thompson, JP Bouffard, GD Sandberg, et al. (2003) Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature. Mod Pathol 16 236-245.
170. D Erickson, et al. (2001) Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metabol 86 5210-5216.
171. L Sennaroglu and A Sungur (2002) Histopathology of paragangliomas. Otol Neurotol 23 104-105.
172. KY Lam, CY Lo, NM Wat, et al. (2001) The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas. J Clin Pathol 54 443-448.
173. F Martinez-Madrigal, J Bosq, C Micheau, et al. (1991) Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuroendocrine carcinomas. Pathol Res Pract 187 814-823.
174. EL Barnes and S Taylor (1991) Carotid body paragangliomas: a clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol 116 447-453.
175. KW Min (1998) Diagnostic usefulness of sustentacular cells in paragangliomas: immunocytochemical and ultrastructural investigation. Ultrastruct Pathol 22 369-376.
176. E Achilles, BC Padberg, K Holl, et al. (1991) Immunocytochemistry of paragangliomas – value of staining for S100 protein and glial fibrillary acidic protein in diagnosis and prognosis. Histopathology 18 458.
177. KE Kliewer, DR Wen and PA Cancilla (1989) Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol 20 29-39.
178. EE Mooney, LG Dodd, TD Oury, et al. (1999) Middle ear carcinoid: an indolent tumor with metastatic potential. Head Neck 21 72-77.
179. CM Mandigers, AP van Gils, J Derksen, et al. (1996) Carcinoid tumor of the jugulotympanic region. J Nuclear Med 37 270-272.
180. JL Hunt, JE Tomaszewski and KT Montone (2004) Prostatic adenocarcinoma metastatic to the head and neck and the workup of an unknown epithelioid neoplasm. Head Neck 26 171-178.
181. JA Ozolek, S Bastacky, E Myers, et al. (2005) Immunohistochemical staining characteristics of oncocytomas of major salivary glands: comparison to conventional renal cell carcinoma. Laryngoscope 115 1097-1100.
182. MY Khalil, JR Grandis and DM Shin (2003) Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer. Expert Review of Anticancer Therapy 3 367-380.
183. S Iqbal and HJ Lenz (2004) Integration of novel agents in the treatment of colorectal cancer. Cancer Chemother Pharmacol 54 S32-S39.
184. E Diaz-Rubio (2004) New chemotherapeutic advances in pancreatic, colorectal, and gastric cancers. Oncologist 9 282-294.
185. MB Resnick, J Routhier, T Konkin, et al. (2004) Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res 10 3069-3075.
186. Y Kondo, EF Hollingsworth and S Kondo (2004) Molecular targeting for malignant gliomas (review). Int J Oncology 24 1101-1109.
187. B Li, CM Chang, M Yuan, et al. (2003) Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas. Cancer Res 63 7443-7450.
188. A Nadal and A Cardesa (2003) Molecular biology of laryngeal squamous cell carcinoma. Virchows Archiv 442 1-7.
189. AC Ford and JR Grandis (2003) Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 25 67-73.
190. JG Paez, PA Janne, JC Lee, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304 1497-1500.
191. TJ Lynch, DW Bell, R Sordella, et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350 2129-2139.
192. H Yaziji and AM Gown (2004) Testing for epidermal growth factor receptor in lung cancer: have we learned anything from HER-2 testing? J Clin Oncol 22 3646-3648.
193. M Gasco and T Crook (2003) The p53 network in head and neck cancer. Oral Oncol 39 222-231.
194. H Blons and P Laurent-Puig (2003) TP53 and head and neck neoplasms. Hum Mutation 21 252-257.
195. VM van Houten, MP Tabor, MW van den Brekel, et al. (2002) Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol 198 476-486.
196. R Vielba, J Bilbao, A Ispizua, et al. (2003) p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Laryngoscope 113 167-172.
197. BD Smith and BG Haffty (1999) Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiation Oncol Investigat 7 125-144.
198. JL Hunt, ZW Baloch and VA LiVolsi (2002) Sentinel lymph node evaluation for tumor metastasis. Sem Diagn Pathol 19 263-277.
199. JC Sniezek, KE Matheny, MD Westfall, et al. (2004) Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope 114 2063-2072.
200. PA Fregonesi (2003) P16INK4A immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 51 1291-1297.
201. A Namazie, S Alavi, OI Olopade, et al. (2002) Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 112 472-481.
202. ML Schoelch, et al. (1999) Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 35 333-342.
203. RJ Oliver, DG MacDonald and DH Felix (2000) Aspects of cell proliferation in oral epithelial dysplastic lesions. J Oral Pathol Med 29 49-55.
204. LA Kresty, SR Mallery, TJ Knobloch, et al. (2002) Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res 62 5295-5300.
205. P Ambrosch, T Schlott, D Hilmes, et al. (2001) p16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract. Virchows Archiv 438 343-349.